Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Change In Inventory : $-1,223 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Takeda Pharmaceutical Co Change In Inventory?

Takeda Pharmaceutical Co's change in inventory for the quarter that ended in Dec. 2023 was $-351 Mil. It means Takeda Pharmaceutical Co's inventory increased by $351 Mil from Sep. 2023 to Dec. 2023 .

Takeda Pharmaceutical Co's change in inventory for the fiscal year that ended in Mar. 2023 was $-592 Mil. It means Takeda Pharmaceutical Co's inventory increased by $592 Mil from Mar. 2022 to Mar. 2023 .

Takeda Pharmaceutical Co's Total Inventories for the quarter that ended in Dec. 2023 was $8,124 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Takeda Pharmaceutical Co's Days Inventory for the quarter that ended in Dec. 2023 was 275.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. Takeda Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 0.33.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Takeda Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 1.03.

Takeda Pharmaceutical Co Change In Inventory Historical Data

The historical data trend for Takeda Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Change In Inventory Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Inventory

Get a 7-Day Free Trial

456.32

1,277.01

238.99

-389.18

-592.19

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-136.84	-336.03	-202.25	-333.79	-351.10

Takeda Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1,223 Mil.

Takeda Pharmaceutical Co (NYSE:TAK) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Takeda Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	7970.8185	/	2635.623	*	365 / 4
	=	275.96

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Takeda Pharmaceutical Co's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2635.623	/	7970.8185
	=	0.33

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Takeda Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	7970.8185	/	7717.561
	=	1.03

Takeda Pharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.